Previous section Next section
GLUCOSE HOMEOSTASIS
Body_ID: HC020011
In the fasting state, glucoseView drug information turnover in a 70 kg (154 lb) individual is approximately 2 mg/kg/min (200 g/24 h). The plasma glucoseView drug information concentration reflects the balance between intake (glucoseView drug information absorption from the gut), tissue utilization (glycolysis, pentose phosphate pathway, tricarboxylic acid (TCA) cycle, glycogen synthesis) and endogenous production (glycogenolysis and gluconeogenesis). GlucoseView drug information homeostasis is controlled primarily by the anabolic hormone insulin and also by several insulin-like growth factors. Several catabolic hormones (glucagon, catecholamines, cortisol, and growth hormone) oppose the action of insulin; they are known as anti-insulin or counter-regulatory hormones (Fig. 20.1).
Body_ID: P020009
Body_ID: P020010
Body_ID: F020001
Figure 20.1 Hormonal control of glucoseView drug information homeostasis. Plasma glucoseView drug information concentration reflects the balance between the hypoglycemic action of insulin and the hyperglycemic action of anti-insulin hormones. The lower part of the figure illustrates the daily patterns of insulin, glucagon and plasma glucoseView drug information concentrations. GlucoseView drug information concentration throughout the day remains in a relatively narrow range (see also Fig. 12.1). To obtain glucoseView drug information concentrations in mg/dL, multiply by 18.
Insulin and glucagon are the main hormones responsible for controlling plasma glucoseView drug information levels
Body_ID: HC020014
Insulin is secreted from the pancreas in response to the increase in plasma glucoseView drug information following a meal. Insulin decreases the plasma glucoseView drug information concentration by promoting the uptake of glucoseView drug information into tissues, intracellular glucoseView drug information metabolism, and glycogen synthesis. Anti-insulin hormones stimulate both the release of glucoseView drug information from glycogen stores and its de novo synthesis, thus causing an increase in glucoseView drug information concentration in plasma (hyperglycemia). The balance between the effects of insulin and glucagon is a key factor in the control of fuel metabolism. Insulin and glucagon are both secreted from the same anatomic location - the pancreatic islets of Langerhans. Insulin is secreted by β-cells (which constitute approximately 70% of all islet cells) and glucagon is secreted by the α-cells.
Body_ID: P020011
Body_ID: P0275
Previous section
Bar end Bar end
Next section
Copyright © 2007 Elsevier Inc. All rights reserved. Read our Terms and Conditions of Use and our Privacy Policy.
For problems or suggestions concerning this service, please contact: studentconsult.help@elsevier.com